Anastrozol - off‑label použití u mužů

Warning

This publication doesn't include Institute of Computer Science. It includes Faculty of Medicine. Official publication website can be found on muni.cz.

Title in English	Anastrozole - off-label use in men
Authors	TURJAP Miroslav KRÁL Roman JUŘICA Jan
Year of publication	2023
Type	Article in Periodical
Magazine / Source	Farmacie pro praxi - Praktické lékárenství
MU Faculty or unit	Faculty of Medicine
Citation
Web	https://www.solen.cz/artkey/lek-202301-0002_anastrozol_-_off_8209_label_pouziti_u_muzu.php
Keywords	anastrozole; aromatase inhibitors; men; off-label use; clinical trials
Description	Anastrozole is a highly selective nonsteroidal aromatase inhibitor. It is approved for the treatment of hormone receptor-positive breast cancer in postmenopausal women. Nonetheless, aromatase inhibitors have also been used off-label for many years in men. This article outlines empirical non-oncological anastrozole uses in men and briefly presents some current clinical trials involving the male population.
Related projects:	Preklinický a klinický výzkum Farmakologického ústavu v oblasti farmakokinetiky, neurobiologie závislostí a personalizované farmakoterapie v onkologii